AI-Powered Infectious Disease Intelligence in Pharmaceutical Organizations
Knowing where disease is today — and where it will be tomorrow — is crucial for maintaining a competitive edge in the pharmaceutical and life science sectors. But traditional approaches to gathering and analyzing biothreat intelligence are highly resource-intensive, and suffer from critical data gaps.
Read the full whitepaper to learn:
- How to improve market research using high-resolution, geographically-granular infectious disease data
- Strategies for enhancing market segmentation and sales-force targeting
- Examples of how predictive biothreat intelligence can inform demand forecasting and supply chain management